Delayed-type hypersensitivity-like mechanisms dominate late acute rejection episodes in renal allograft recipients

Transplantation

Volumn 61, Issue 8, 1996, Pages 1233-1240

  Ode Hakim, Susanne ^a   Döcke, Wolf Dietrich ^a   Kern, Florian ^a   Emmrich, Frank ^b   Volk, Hans Dieter ^a   Reinke, Petra ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; SERINE PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; GENE EXPRESSION; GRAFT REJECTION; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

CYTOKINES; GRAFT REJECTION; GRANZYMES; HUMANS; HYPERSENSITIVITY, DELAYED; KIDNEY TRANSPLANTATION; SERINE ENDOPEPTIDASES; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

EID: 0029911802     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604270-00020     Document Type: Article

References (38)

1. Sablinski T, Hancock WW, Tilney NL, Kupiec-Weglinski JW. CD 4 monoclonal antibodies in organ transplantation - a review of progress. Transplantation 1991; 52: 579.
2. Lowry RP, Forbes RD, Blackburn JH, Marghesco DM. Immune mechanisms in organ allograft rejection: V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat. Transplantation 1985; 40: 545.
3. Hancock WW, Thomson NM, Atkins RC. Composition of interstitial cellular infiltrates in renal biopsies of rejecting human renal transplants identified by monoclonal antibodies. Transplantation 1983; 35: 458.
4. Hancock WW, Gee D, de Moerloose P, et al. Immunohistological analysis of serial biopsies taken during human renal allograft rejection: changing pattern of infiltrating cells and involvement of the coagulation system. Transplantation 1985; 39: 430.
5. Hancock WW. Analysis of intragraft effector mechanisms associated with human renal allograft rejection: immunohistological studies with monoclonal antibodies. Immunol Rev 1984; 77: 61.
6. Raul RJ, Russ GR. Tubular expression of intercellular adhesion molecule-1 during renal allograft rejection. Transplantation 1989; 48: 2.
7. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537.
8. Tsuchida A, Salem H, Thomson N, Hancock WW. Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free pro-tein S levels and decreased intragraft thrombomodulin expression. J Exp Med 1992; 175: 81.
9. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
10. Dallman MJ, Roake J, Hughes D, Toogood G, Morris PJ. Sequential analysis of IL-2 gene transcription in renal transplants. Transplantation 1992; 53: 683.
11. Martinez OM, Krams SM, Sterneck M, et al. Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992; 53: 449.
12. Wu CJ, Lovett M, Wong-Lee J, et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992; 54: 326.
13. Williamson P, Allen RDM, Chapman JR, Stewart GJ. Analysis of mRNA in renal allografts using polymerase chain reaction amplification. Transplant Proc 1992; 24: 205.
14. Nast CC, Zuo XJ, Prehn J, Danovitch GM, Wilkinson A, Jordan SC. Gamma-interferon gene expression in human renal allograft fine needle aspirates. Transplantation 1994; 57: 498.
15. Vandenbroecke C, Caillat-Zucman S, Legendre C, et al. Differential in situ expression of cytokines in renal allograft rejection. Transplantation 1991; 51: 602.
16. Noronha IL, Eberlein-Gonska M, Hartley B, et al. In situ expression of tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 receptors in renal allograft biopsies. Transplantation 1992; 54: 1017.
17. Morel D, Nordmand E, Lemoine C, et al. Tumor necrosis factor alpha in human kidney transplant rejection-analysis by in situ hybridization. Transplantation 1993; 55: 773.
18. Lipman ML, Stevens AC, Bleckley RC, et al. The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection. Transplantation 1992; 53: 73.
19. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120.
20. Reinke P, Fietze E, Döcke WD, Kern F, Ewert R, Volk HD. Late acute rejection in long-term renal allograft recipients. Transplantation 1994; 58: 35.
21. Mahoney JF, Sheil AGR, Etheredge SB, et al. Delayed complications of renal transplantation. Med J Aust 1982; 2: 262.
22. Mahoney JF, Sheil AGR. Long-term complications of cadaver renal transplantation. In: Morris PJ, Tilney NL, eds. Transplantation, reviews. New York: Grune & Stratton, 1987: 47.
23. Rao KV, Kasiske BL, Bloom PM. Acute graft rejection in the late survivors of renal transplantation. Transplantation 1989; 47: 290.
24. Prieto C, Pulido F, Rodriguez-Paternina E, et al. Late acute rejection in renal transplant recipients: response to steroid treatment. Transplant Proc 1992; 24: 35.
25. Platzer C, Ode-Hakim S, Reinke P, et al. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 1994; 58: 264.
26. Hammer C. Cytology in transplantation. Percha, Germany: Schulz, 1989.
27. Häyry P, von Willebrand E. Transplant aspiration cytology. Transplantation 1984; 38: 7.
28. Emmrich F, Burmeister G, Horneff G, et al. Treatment of autoimmune diseases and transplant rejection with anti-CD 4 monoclonal antibodies. Z Ges Inn Med 1992; 47: 500.
29. Reinke P, Volk HD, Miller H, et al. Anti-CD4 therapy of acute rejection in long-term renal allograft recipients. Lancet 1991; 338: 702.
30. Platzer C, Richter G, Überla K, et al. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur J Immunol 1992; 22: 1179.
31. Kern F, Döcke WD, Reinke P, et al. Discordant expression of LFA-1, VLA-alpha4, VLA-beta1, CD 45RO and CD 28 on T-cell subsets-evidence for multiple subsets of "memory"-T cells. Int Arch Allerg Immunol 1994; 104: 17.
32. Kern F, Ode-Hakim S, Nugel H, Volk HD, Reinke P. CD3+/ LFA-1 "bright" T cells represent memory-type effector cells, which, during immune activation in kidney graft recipients, are marked by increased cytokine mRNA levels. Transplant Proc 1995; 27: 896.
33. Turunen JP, Mattila P, Halttunen J, et al. Evidence that lymphocyte traffic into rejecting cardiac allografts is CD 11a and CD 49d dependent. Transplantation 1992; 54: 1053.
34. Ibrahim S, Dawson DV, Sanfilippo F. Predominant infiltration of rejecting human renal allografts with T cells expressing CD 8 and CD 45RO. Transplantation 1995; 59: 724.
35. Schulz M, Schuurman HJ, Joergensen J, et al. Acute rejection of vascular heart allografts by perforin-deficient mice. Eur J Immunol 1995; 25: 474.
36. Martin DR, Miller RG. In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors. J Exp Med 1989; 170: 679.
37. Mathew JM, Marsh JW, Susskind B, Mohanakumar T. Analysis of T cell responses in liver allograft recipients: evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation. J Clin Invest 1993; 91: 900.
38. Berke G. The CTL's kiss of death. Cell 1995; 81: 9.